During obesity and related complications such as type 2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease, the circulating level of Alpha-2-HS-glycoprotein is significantly increased (52). This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.